| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |